Cardiotoxicity Clinical Trial
Official title:
Effect of Trimetazidine on Radiotherapy-induced Heart Damage in Lung Tumor Patients Treated With Stereotactic Body Radiotherapy.
This is a randomized controlled trial. 80 patients with thoracic radiotherapy will be included. Participants will be randomly divided into experimental group or control group. Before radiotherapy, echocardiography, 2D STE, CK, CK-MB, cTnT, NT-proBNP, electrocardiogram (ECG), and hs-CRP will be detected. During subsequent follow-up, echocardiography, 2D STE, CK, CK-MB, cTnT, NT-proBNP, ECG, and hs-CRP will be collected at every follow-up time.
This is a randomized controlled trial. 80 patients with thoracic radiotherapy will be included in Peking University Third Hospital from May 15, 2021 to August 31, 2022. Participants will be randomly divided into experimental group or control group. Before radiotherapy, echocardiography, 2D STE, CK, CK-MB, cTnT, NT-proBNP, electrocardiogram (ECG), and hs-CRP will be detected. All participants will be followed up after completion of RT, 3 months after RT, 6 months after RT, and 12 months after RT. During subsequent follow-up, echocardiography, 2D STE, CK, CK-MB, cTnT, NT-proBNP, ECG, and hs-CRP will be collected at every follow-up time. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05271162 -
Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines
|
Phase 3 | |
| Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
| Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
| Recruiting |
NCT04092309 -
Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation
|
N/A | |
| Recruiting |
NCT04790266 -
Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer Patients
|
||
| Enrolling by invitation |
NCT04305613 -
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy
|
||
| Not yet recruiting |
NCT05040867 -
Exercise Prescription Guided by Heart Rate Variability in Breast Cancer Patients
|
N/A | |
| Recruiting |
NCT05851053 -
Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
|
||
| Recruiting |
NCT05992337 -
New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.
|
||
| Enrolling by invitation |
NCT04877899 -
Mazankowski Alberta Heart Institute (MAHI) EchoGo Discovery 1 Protocol
|
||
| Recruiting |
NCT05096338 -
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
|
||
| Recruiting |
NCT05078190 -
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer
|
||
| Recruiting |
NCT04632407 -
Can Flaxseed Prevent Broken Hearts in Women With Breast Cancer Study?
|
N/A | |
| Completed |
NCT00543062 -
Staccato Prochlorperazine Thorough QT/QTc
|
Phase 1 | |
| Recruiting |
NCT05159479 -
Defining Robust Predictors of Chemotherapy Related Cardiotoxicity
|
||
| Not yet recruiting |
NCT06005259 -
Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)
|
Phase 4 | |
| Recruiting |
NCT05406635 -
Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer
|
N/A | |
| Recruiting |
NCT04047901 -
Effect of Physical Training in Patients With Heart Failure Caused by Chemotherapy for Cancer Treatment
|
N/A | |
| Terminated |
NCT03038997 -
Early Detection of Cardiac Toxicity in Childhood Cancer Survivors
|
||
| Completed |
NCT01246778 -
Sunitinib and Atrial Trabeculae Contractility
|
N/A |